In Alzheimer’s disease (AD), microglial clearance regulates the turnover of neurotoxic danger-associated molecular patterns (DAMPs), including amyloid-beta (Aβ), hyperphosphorylated tau and dystrophic neurites1–5. Here, MAPT is linked to Alzheimer disease.